I have been on intermittent ADT with Lupron and Casodex since 9/2011.
Recently my PSA seems to becoming insensitive to the treatment and my MO said we should start thinking about next steps: Xtandi, Zytiga etc. But before we do that he suggested I stop taking the Casodex as that sometimes causes the PSA to drop. Well it did.
Anyone have experience with this and any idea how long it might last. I have read anywhere from 4 months to 2 years.
Written by
Joeym1040
To view profiles and participate in discussions please or .
Nothing unusual. After stopping Bicalutamide, PSA can drop and it is called Bicalutamide withdrawal reaction. Sometimes, this drop in PSA can last months and even years. Cheers.
It doesn't last long. It happens because your cancer has adapted by learning how to feed on Casodex. I wouldn't wait for PSA progression to start Zytiga or Xtandi.
You have no profile so I can't tell if you've had metastases detected or not. The medicines available to you will depend on that.
You are in unknown territory about combining estrogen with second-line hormonal agents. I am just guessing, but I would think it would be OK because high doses of estrogen act as a GnRH antagonist.
So because you are non-metastatic and castration-resistant, you qualify for Xtandi, Erleada, and Nubiqa (Zytiga has not yet been approved for this situation, although the IMAAGEN clinical trial look good). I don't have a strong opinion about one over the others, and there have never been any comparative tests. Nubiqa may cause less fatigue and have lower risk of seizures but it really hasn't been proven.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.